Delivery Order SPE2DB20D3103-SPE2DB25FM6F7
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.96 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on January 22, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,731.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through November 27, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,670.56 and has a completion date of January 17, 2025. It is a Firm Fixed Price contract for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
The federal contract award, valued at $1,387.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of February 10, 2025 and is a Firm Fixed Price contract. No set-aside was used for this award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,602.79 Firm Fixed Price Delivery Order is for the supply of FYCOMPA 0.5 mg/ml Oral Suspension in 340 ml bottles. The contract has an ultimate completion date of October 18, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Fycompa 4 mg tablets, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,033.98 firm-fixed-price delivery order has a completion date of December 11, 2024 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
This federal contract award to Amerisourcebergen Drug Corp is a $9,774.38 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract provides the pharmaceutical product FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. No set-aside designation is indicated, suggesting this was an open competition contract. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,169.29 with a firm fixed price and an ultimate completion date of January 16, 2025. The contract is for the supply of FYCOMPA 2 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,922.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.98 firm fixed-price delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...